Baylor College of Medicine: Study Shows Long-Term Safety of Genetically Modified Immune Effector Cells
March 31, 2022
March 31, 2022
HOUSTON, Texas, March 31 (TNSJou) -- The Baylor College of Medicine issued the following news:
A new study from researchers at the Center for Cell and Gene Therapy at Baylor College of Medicine, Texas Children's Hospital and Houston Methodist Hospital shows that cancer patients who receive treatment with genetically modified immune cells (IECs) are not at increased risk for subsequent malignancy when compared to patients who receive standard chemotherapy. The results are publis . . .
A new study from researchers at the Center for Cell and Gene Therapy at Baylor College of Medicine, Texas Children's Hospital and Houston Methodist Hospital shows that cancer patients who receive treatment with genetically modified immune cells (IECs) are not at increased risk for subsequent malignancy when compared to patients who receive standard chemotherapy. The results are publis . . .